comparemela.com

Rlab Therapeutics Ab News Today : Breaking News, Live Updates & Top Stories | Vimarsana

IRLAB to Present at Life Science-dagen in Gothenburg and have a Fireside Chat with ABG

GOTHENBURG, SWEDEN / ACCESSWIRE / February 29, 2024 / IRLAB Therapeutics (STO:IRLAB-A)(FRA:6IRA) Gothenburg, Sweden, February 29, 2024 - IRLAB Therapeutics AB (Nasdaq Stockholm: IRLAB A), a company discovering and developing novel treatments for Parkinson's .

Vastra gotalands lanViktor siewertzArvid carlssonMichaelj fox foundationWallenberg conference centreNasdaq stockholmLife science dagenNobel laureateIntegrative screening processRlab therapeutics abViktor siewertzFireside chatNasdaq stockholm

IRLAB has Completed a Successful End-of-Phase 2 Meeting with the FDA on the Design of the Phase III Program for Mesdopetam

GOTHENBURG, SWEDEN / ACCESSWIRE / February 22, 2024 / IRLAB Therapeutics (STO:IRLAB-A)(FRA:6IRA) Gothenburg, Sweden, 22 February 2024 - IRLAB Therapeutics AB (Nasdaq Stockholm: IRLAB A), a company discovering and developing novel treatments for Parkinson's .

Vastra gotalands lanGunnar olssonArvid carlssonMichaelj fox foundationNasdaq stockholmNobel laureateIntegrative screening processIrlab therapeuticsFood and drug administrationPhase iiaMeeting minutesArkinson 39s diseaseRlab therapeutics abPhase iiiPreclinical studiesNasdaq stockholm

IRLAB is Granted an End-of-Phase 2 Meeting with the FDA for the Phase III-Ready Mesdopetam Program

GOTHENBURG, SWEDEN / ACCESSWIRE / January 3, 2024 / IRLAB Therapeutics (STO:IRLAB-A) (FRA:6IRA) Gothenburg, Sweden, January 3, 2024 - IRLAB Therapeutics AB (Nasdaq Stockholm: IRLAB A), a company discovering and developing novel treatments for Parkinson's .

Vastra gotalands lanGunnar olssonArvid carlssonPropharma groupMichaelj fox foundationNasdaq stockholmNew drug applicationBriefing bookNobel laureateIntegrative screening processIrlab therapeuticsS fdaGunnar olssonReatment for parkinson 39s diseasePhase iiiArkinson 39s disease

vimarsana © 2020. All Rights Reserved.